|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06955 BOAN BIOTECH
Nominal 
0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 64,889 | (117,936) | (18,568) | (201,841) |
| Net Cash from / (used in) Investing Activities | -- | (274,047) | (362,893) | (293,571) | (100,684) |
| Net Cash from / (used in) Financing Activities | -- | 1,140,907 | 477,832 | 283,086 | (127) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 931,749 | (2,997) | (29,053) | (302,652) |
| Cash & Cash Equivalents at beginning of period | -- | 198,867 | 201,850 | 233,498 | 531,703 |
| Effect of Foreign Exchange Rate Changes | -- | (214) | 14 | (2,595) | 4,447 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,130,402 | 198,867 | 201,850 | 233,498 |
| Remarks: | Real time quote last updated: 10/09/2026 07:45 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -83,009 |
| %Change | -- |
| EPS / (LPS) | RMB -0.130 |
| NBV Per Share (¥) | RMB 4.275 |